Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Lyra Influenza A+B Assay

K-Number: K230236 · 2023-03-03

Decision Date2023-03-03
Product CodeOZE
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Lyra Influenza A+B Assay is the device name listed in this FDA 510(k) record. The listed applicant is Quidel Corporation. It received FDA 510(k) clearance on 2023-03-03 under 510(k) number K230236. The device is classified under product code OZE. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Lyra Influenza A+B Assay?

Lyra Influenza A+B Assay is a medical device that received FDA 510(k) clearance on 2023-03-03. The listed applicant is Quidel Corporation. The 510(k) number is K230236.

When did Lyra Influenza A+B Assay receive FDA 510(k) clearance?

Lyra Influenza A+B Assay received FDA 510(k) clearance on 2023-03-03, under 510(k) number K230236.

Who is the listed applicant for Lyra Influenza A+B Assay?

The FDA 510(k) record lists Quidel Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Lyra Influenza A+B Assay?

The FDA product code for Lyra Influenza A+B Assay is OZE.

Other records listing Quidel Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 22 devices →

Related Devices (Code: OZE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.